000 01432 a2200409 4500
005 20250518050356.0
264 0 _c20200610
008 202006s 0 0 eng d
022 _a1520-4804
024 7 _a10.1021/acs.jmedchem.9b00411
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBou Karroum, Nour
245 0 0 _aNovel and Selective TLR7 Antagonists among the Imidazo[1,2-
_h[electronic resource]
260 _bJournal of medicinal chemistry
_c08 2019
300 _a7015-7031 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCell Line
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aImidazoles
_xchemistry
650 0 4 _aProtein Structure, Secondary
650 0 4 _aPyrazines
_xchemistry
650 0 4 _aQuinoxalines
_xchemistry
650 0 4 _aToll-Like Receptor 7
_xantagonists & inhibitors
700 1 _aMoarbess, Georges
700 1 _aGuichou, Jean-François
700 1 _aBonnet, Pierre-Antoine
700 1 _aPatinote, Cindy
700 1 _aBouharoun-Tayoun, Hasnaa
700 1 _aChamat, Soulaima
700 1 _aCuq, Pierre
700 1 _aDiab-Assaf, Mona
700 1 _aKassab, Issam
700 1 _aDeleuze-Masquefa, Carine
773 0 _tJournal of medicinal chemistry
_gvol. 62
_gno. 15
_gp. 7015-7031
856 4 0 _uhttps://doi.org/10.1021/acs.jmedchem.9b00411
_zAvailable from publisher's website
999 _c29879220
_d29879220